CRP, produced in response to cytokines such as interleukin-6 and tumor necrosis factor-α, reflects chronic low-grade inflammation that promotes insulin resistance, endothelial dysfunction, and dyslipidemia [27]. The gene discussed is IL6; the disease is metabolic syndrome.